MARKET

BMRA

BMRA

Biomerica
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.53
+0.03
+0.55%
Closed 16:00 03/08 EST
OPEN
5.47
PREV CLOSE
5.50
HIGH
5.74
LOW
5.46
VOLUME
53.54K
TURNOVER
--
52 WEEK HIGH
23.39
52 WEEK LOW
2.050
MARKET CAP
65.14M
P/E (TTM)
-13.8736
1D
5D
1M
3M
1Y
5Y
Blood Testing Market Share, Size, Trends, Industry Analysis to 2027 by Disease Type; By Technology; By Specialty; By End-Use; By Regions
Mar 08, 2021 (Heraldkeepers) -- The Blood Testing Market is expected to exceed more than US$ 60.8 Billion by 2024 at a CAGR of 2.5% in the given forecast...
Heraldkeepers · 9h ago
Cancer Test Kit Market Size Research Report 2021 by Growth Potential, Market Share, Price and Forecast to 2027 Says Absolute Reports
Mar 08, 2021 (The Expresswire) -- “Cancer Test Kit Market” forecast 2027 report gives a comprehensive overview, market size, shares and growth opportunities...
The Express Wire · 15h ago
Point-of-Care Testing Market Trends 2021 Global Industry Size, Share, Revenue, Business Growth, Demand and Applications Market Research Report to 2026
Mar 02, 2021 (The Expresswire) -- The Point-of-Care Testing industry has undergone many changes in recent years and expects numerous variations in the coming...
The Express Wire · 6d ago
Serology Test Market Size, Share, Growth, Research and Forecast 2020-2026
Mar 02, 2021 (Market Insight Reports) -- The global serology test market is expected to grow at a significant CAGR during the forecast period. The increase...
Market Insight Reports · 6d ago
Helicobacter Pylori Rapid Test Kit Market Size 2021 by Opportunities, Challenges, Risks, Influences Factors Analysis and Forecast to 2025 Research Report by Absolute Reports
Mar 01, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Helicobacter Pylori Rapid Test Kit Market...
The Express Wire · 03/01 11:18
Global Fecal Occult Blood (FOBT) Rapid Diagnostic Test Market 2020 Business Growth Rate, Manufacturing Analysis, Size, Share, Cost Structure and Forecast to 2025
Feb 28, 2021 (CDN Newswire via Comtex) -- Global Fecal Occult Blood (FOBT) Rapid Diagnostic Test Market 2020 by Company, Type and Application, Forecast to...
CDN Newswire · 02/28 06:51
Global Fecal Occult Blood Diagnostic Kits Market 2020 Industry Manufacturing Size, Share, Business Insights, Key Challenges and Forecast Analysis by 2025
Feb 28, 2021 (CDN Newswire via Comtex) -- MarketsandResearch.biz has added a new key research report entitled Global Fecal Occult Blood Diagnostic Kits...
CDN Newswire · 02/28 06:49
Creatine Kinase Test Kit Market : Size, Share, Industry Price, Report and Forecast To 2027
Japan, Japan, Thu, 25 Feb 2021 06:42:17 / Comserve Inc. / -- Competitive Analysis: Merck, Biomerica, Abcam, Roche Diagnostics, Hologic, Thermo Fisher...
Comserve · 02/25 11:44
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BMRA. Analyze the recent business situations of Biomerica through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BMRA stock price target is 10.88 with a high estimate of 13.00 and a low estimate of 9.50.
EPS
Institutional Holdings
Institutions: 47
Institutional Holdings: 3.00M
% Owned: 25.43%
Shares Outstanding: 11.78M
TypeInstitutionsShares
Increased
11
1.13M
New
9
127.06K
Decreased
7
85.11K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.72%
Healthcare Equipment & Supplies
-1.34%
Key Executives
Chairman/Director/Chief Executive Officer
Zackary Irani
Vice Chairman/Secretary/Lead Director/Director/Independent Director
Allen Barbieri
Chief Financial Officer
Steve Sloan
Chief Financial Officer
Steven Sloan
Independent Director
Francis Cano
Independent Director
Catherine Coste
Independent Director
Jane Emerson
Independent Director
Cathy Coste
Independent Director
Mark Sirgo
No Data
About BMRA
Biomerica, Inc. is a biomedical company, which develops, manufactures, and markets medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The medical diagnostic products are sold in two markets: clinical laboratories and point of care. The diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications, by measuring or detecting the existence and/or level of specific bacteria, hormones, antibodies, antigens or other substances, which may exist in a patient’s body, stools, or blood, often in extremely small concentrations. Biomerica has developed a diagnostic guided therapy that is designed to allow physicians to identify patient-specific foods, that when removed from the diet, may alleviate or improve an individual's symptoms of Irritable Bowel Syndrome (IBS). This product is called InFoods IBS.

Webull offers kinds of Biomerica, Inc. stock information, including NASDAQ:BMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BMRA stock methods without spending real money on the virtual paper trading platform.